Correlation of Gene Status and Clinical Outcomes in ESCC

LiuJunFeng46 enrolled

Overview

The incidence of esophageal squamous cell carcinoma is highly regional and familial. The current treatment plan is based on the stage and location of the tumor.By studying the relationship between the status of different genes and prognosis, it can help doctors to develop precise and individualized treatment plans.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Prognosis of Patients With ESCC

Eligibility

Sex: ALLMin age: 30 YearsMax age: 80 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Esophageal cancer patients who underwent surgery treatment, and postoperative pathological diagnosis was squamous cell carcinoma. Patients with ESCC have complete clinical information. Exclusion Criteria: * Patients who also suffering from other tumors.

Locations (1)

Junfeng Liu

Shijiazhuang, Hebei, China

RECRUITING

Outcomes

Primary Outcomes

Gene test

466 Tumor-associated gene test by next-generation sequencing(NGS)

Time frame: 2019-2 to 2019-4

Central Contacts

Junfeng Liu, MD

CONTACT

13931152296 13931152296@163.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.